VRPX   $0.6695  -45.12% Market Open

Virpax Pharmaceuticals, Inc.
Total Cash 1.87M
totalCashPerShare 0.383
EBITDA
Total Debt 0.00
quickRatio 0.347
currentRatio 0.481
Total Revenue
debtToEquity
Revenue/Share
ROA -0.91415
ROE -3.6228602
grossProfits
freeCashflow -5.98M
operatingCashflow -15.04M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.61M
forwardPE -0.7916667
floatShares 4.59M
sharesOutstanding 4.89M
sharesShort 565.47K
sharesShortPriorMonth 415.26K
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.00%
Short Ratio help_outline 2.92%
shortPercentOfFloat 0.12%
impliedSharesOutstanding
bookValue -0.985
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -17.23M
trailingEps -13.64%
forwardEps -0.90%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.54 3Q 2024
institutionsCount 8
lastUpdated Nov. 7, 2024, 4:55 a.m.